PAPER
One-Pot Synthesis of Sulfonamides
3987
N,N-Diisopropyl-4-methylbenzenesulfonamide (Table 2, Entry
4-Benzyl-1-[(4-methylphenyl)sulfonyl]piperidine (Table 2,
Entry 15)
8)
IR (KBr): 2939, 2854, 1458, 1334, 1157 cm–1.
IR (KBr): 3031, 2908, 1566, 1311, 1234 cm–1.
1H NMR (250 MHz, CDCl3): d = 1.02 (d, 12 H, J = 4.5 Hz, 4 CH3),
2.30 (s, 3 H, CH3), 2.75–2.80 (m, 2 H, 2 CH), 7.17 (d, 2 H, J = 7.5
Hz, ArH), 7.66 (d, 2 H, J = 7.5 Hz, ArH).
13C NMR (62.5 MHz, CDCl3): d = 21.4, 25.3, 30.2, 126.9, 129.6,
137.4, 142.8.
1H NMR (250 MHz, CDCl3): d = 0.99–1.17 (m, 1 H, CH), 1.57–
1.73 (m, 4 H, CH2CHCH2), 2.45 (s, 3 H, CH3), 2.58 (t, 4 H, J = 5.6
Hz, 2 NCH2), 4.55 (d, 2 H, J = 12.5 Hz, PhCH2), 7.02–7.21 (m, 9 H,
ArH).
13C NMR (62.5 MHz, CDCl3): d = 31.8, 32.1, 38.3, 43.1, 43.8,
126.0, 128.3, 129.2, 136.5, 138.4, 140.1, 144.1, 149.6.
MS (EI): m/z (%) = 255.1 (30) [M+].
MS (EI): m/z (%) = 329.1 (38) [M+].
Anal. Calcd for C13H21NO2S: C, 61.14; H, 8.29; N, 5.48; S, 12.56.
Found: C, 61.10; H, 8.33; N, 5.44; S, 12.60.
Anal. Calcd for C19H23NO2S: C, 69.27; H, 7.04; N, 4.25; S, 9.73.
Found: C, 69.32; H, 7.09; N, 4.31; S, 9.77.
N,N,4-Trimethylbenzenesulfonamide (Table 2, Entry 9)
IR (KBr): 3100, 2862, 1458, 1157 cm–1.
4-Benzyl-1-(methylsulfonyl)piperazine (Table 2, Entry 17)
IR (KBr): 3029, 2915, 1566, 1312, 1237 cm–1.
1H NMR (250 MHz, CDCl3): d = 2.50 (s, 3 H, CH3), 2.58 (s, 6 H, 2
NCH3), 7.33 (d, 2 H, J = 7.5 Hz, ArH), 7.92 (d, 2 H, J = 7.5 Hz,
ArH).
1H NMR (250 MHz, CDCl3): d = 1.33–1.47 (m, 8 H, 4 NCH2), 2.79
(s, 3 H, CH3), 4.04 (s, 2 H, PhCH2), 6.97–7.91 (m, 5 H, ArH).
13C NMR (62.5 MHz, CDCl3): d = 21.5, 37.9, 127.8, 129.6, 132.4,
143.5.
13C NMR (62.5 MHz, CDCl3): d = 39.8, 43.0, 52.1, 61.8, 127.0,
128.1, 128.8, 137.7.
MS (EI): m/z (%) = 199.1 (26) [M+].
MS (EI): m/z (%) = 254.1 (29) [M+].
Anal. Calcd for C9H13NO2S: C, 54.25; H, 6.58; N, 7.03; S, 16.09.
Found: C, 54.23; H, 6.61; N, 6.99; S, 16.07.
Anal. Calcd for C12H18N2O2S: C, 56.67; H, 7.13; N, 11.01; S, 12.61.
Found: C, 56.62; H, 7.15; N, 11.07; S, 12.68.
N,N-Dibutyl-4-methylbenzenesulfonamide (Table 2, Entry 10)
4-Benzyl-1-(methylsulfonyl)piperidine (Table 2, Entry 18)
IR (film): 3025, 2939, 2854, 1458, 1334, 1157 cm–1.
IR (KBr): 3115, 2916, 1567, 1442, 1319, 1141 cm–1.
1H NMR (250 MHz, CDCl3): d = 0.69–0.80 (m, 6 H, 2 CH2CH3),
1.11–1.25 (m, 4 H, 2 CH2CH3), 1.33–1.45 (m, 4 H, 2 NCH2CH2),
2.27 (s, 3 H, ArCH3), 2.95–3.13 (t, 4 H, J = 5.3 Hz, 2 NCH2), 7.18
(d, 2 H, J = 7.6 Hz, ArH), 7.55 (d, 2 H, J = 7.6 Hz, ArH).
13C NMR (62.5 MHz, CDCl3): d = 13.5, 19.8, 21.2, 30.4, 48.0,
126.9, 129.4, 137.0, 142.87.
1H NMR (250 MHz, CDCl3): d = 1.20–1.35 (m, 4 H, CH2CHCH2),
1.50–1.63 (m, 3 H, PhCH2CH), 2.47–2.58 (t, 4 H, J = 5.4 Hz, 2
NCH2), 2.66 (s, 3 H, CH3), 7.04–7.24 (m, 5 H, ArH).
13C NMR (62.5 MHz, CDCl3): d = 31.5, 34.5, 37.5, 42.7, 46.2,
126.1, 128.3, 129.1, 139.7.
MS (EI): m/z (%) = 253.1 (24) [M+].
MS (EI): m/z (%) = 283.2 (20) [M+].
Anal. Calcd for C13H19NO2S: C, 61.63; H, 7.56; N, 5.53; S, 12.66.
Found: C, 61.68; H, 7.59; N, 5.51; S, 12.70.
Anal. Calcd for C15H25NO2S: C, 63.56; H, 8.89; N, 4.94; S, 11.31.
Found: C, 63.49; H, 8.92; N, 4.96; S, 11.29.
Acknowledgment
N-Cyclohexyl-N,4-dimethylbenzenesulfonamide (Table 2,
Entry 11)
We thank Shiraz University of Technology and Shiraz University
Research Councils for partial support of this work.
IR (KBr): 3015, 2931, 1566, 1450, 1334, 1296 cm–1.
1H NMR (250 MHz, CDCl3): d = 1.16–1.19 (m, 6 H, 3 CH2), 1.62–
1.65 (m, 4 H, 2 NCHCH2), 2.33 (s, 3 H, ArCH3), 2.64 (s, 3 H,
NCH3), 3.63–3.72 (m, 1 H, NCH), 7.18 (d, 2 H, J = 8.2 Hz, ArH),
7.59 (d, 2 H, J = 8.2 Hz, ArH).
13C NMR (62.5 MHz, CDCl3): d = 20.9, 24.8, 25.2, 28.1, 29.7, 56.2,
126.3, 129.1, 136.9, 142.3.
References
(1) Hansch, C.; Sammes, P. G.; Taylor, J. B. Comprehensive
Medicinal Chemistry, Vol. 2; Pergamon Press: Oxford,
1990, Chap. 7.1.
MS (EI): m/z (%) = 267.1 (16) [M+].
(2) (a) Kanda, Y.; Kawanishi, Y.; Oda, K.; Sakata, T.; Mihara,
S.; Asakura, K.; Kanemasa, T.; Ninomiya, M.; Fujimoto,
M.; Kanoike, T. Bioorg. Med. Chem. 2001, 9, 897.
(b) Mincione, F.; Starnotti, M.; Menabuoni, L.; Scozzafava,
A.; Casini, A.; Supuran, C. T. Bioorg. Med. Chem. Lett.
2001, 11, 1787. (c) Bhusari, K. P.; Khedekar, P. B.; Umathe,
S. N.; Bahekar, R. H.; Rao, A. R. R. Indian J. Heterocycl.
Chem. 2000, 9, 213. (d) Eckenberg, P.; Reefschläger, J.;
Bender, W.; Goldmann, S.; Härter, M.; Hallenberger, S.;
Keldenich, J.; Weber, O.; Henninger, K. DE19934272,
2001; Chem. Abstr.; 2001, 134, 115865. (e) Chibale, K.;
Haupt, H.; Kendrick, H.; Yardley, V.; Saravanamuthu, A.;
Fairlamb, A. H.; Croft, S. L. Bioorg. Med. Chem. Lett. 2001,
11, 2655. (f) Rahavi Ezabadi, I.; Camoutsis, C.;
Anal. Calcd for C14H21NO2S: C, 62.89; H, 7.92; N, 5.24; S, 11.99.
Found: C, 62.85; H, 7.90; N, 5.28; S, 11.97.
1-[(4-Methylphenyl)sulfonyl]pyrrolidine (Table 2, Entry 12)
IR (KBr): 3020, 2970, 1570, 1440, 1334, 1164 cm–1.
1H NMR (250 MHz, CDCl3): d = 1.63–1.68 (m, 4 H, 2 CH2), 2.34
(s, 3 H, ArCH3), 3.11–3.17 (t, 4 H, J = 5.6 Hz, 2 NCH2), 7.22 (d, 2
H, J = 8.0 Hz, ArH), 7.61 (d, 2 H, J = 8.0 Hz, ArH).
13C NMR (62.5 MHz, CDCl3): d = 21.5, 25.1, 47.9, 127.5, 129.6,
133.7, 143.3.
MS (EI): m/z (%) = 225.1 (26) [M+].
Zoumpoulakis, P.; Geronikaki, A.; Soković, M.;
Anal. Calcd for C11H15NO2S: C, 58.64; H, 6.71; N, 6.22; S, 14.23.
Found: C, 58.70; H, 6.65; N, 6.25; S, 14.26.
Glamočilija, J.; Čirič, A. Bioorg. Med. Chem. 2008, 16,
1150. (g) Lavoie, R.; Bouchain, G.; Frechette, S.; Woo,
S. H.; Khalil, E. A.; Leit, S.; Fournel, M.; Yan, P. T.; Trachy-
Synthesis 2009, No. 23, 3983–3988 © Thieme Stuttgart · New York